Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 4 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 1 completed trials have results

Key Signals

2 recruiting

Enrollment Performance

Analytics

No phase data available

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (4)

Showing 4 of 4 trials
NCT07529171Recruiting

HBV Reactivation in Immunocompromised Patients (REANT STUDY)

Role: lead

NCT07459426Not Yet Recruiting

Entecavir Resistance-Associated Mutations in Chronic HBV Patients in Turkey (STREAM Study)

Role: lead

NCT06573190Completed

Liver Status and Presence of MASLD/MASH in Patients With Chronic Hepatitis B

Role: lead

NCT06248580Recruiting

Find HDV and Determine Its Status in Turkey

Role: lead

All 4 trials loaded